MGRM Monogram Technologies Inc

SOUTH SAN FRANCISCO, Calif., Oct. 10 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) announced today that Alfred G. Merriweather, Senior Vice President and Chief Financial Officer, is scheduled to present a corporate overview at the JMP Securities Healthcare Conference on Tuesday, November 13, 2007 at 11:00 a.m. (Eastern Time) at the Four Seasons Hotel in Boston, Massachusetts. To access the live audio broadcast or the subsequent archived recording, log on to http://www.monogrambio.com/ and go to the investor relations section ("Investors/Media" tab) and click on the "Events & Webcasts" link provided on the sidebar menu on the page. About Monogram Biosciences, Inc. Monogram is advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at http://www.monogrambio.com/. Contacts: Alfred G. Merriweather Chief Financial Officer Tel: 650 624-4576 Jeremiah Hall Feinstein Kean Healthcare Tel: 415 677-2700 DATASOURCE: Monogram Biosciences, Inc. CONTACT: Alfred G. Merriweather, Chief Financial Officer of Monogram Biosciences, Inc., +1-650-624-4576, ; or Jeremiah Hall of Feinstein Kean Healthcare for Monogram Biosciences, Inc., +1-415-677-2700, Web site: http://www.monogrambio.com/

Copyright